Gijs G.
- Country
- The Netherlands
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Oncology
The investigator conducts clinical studies across a wide range of malignant neoplasms, integrating targeted agents and immune‑based strategies for both solid tumors and hematologic cancers.
- non‑small cell lung cancer in advanced stages
- breast cancer with metastatic disease
- hematologic malignancies including lymphoma and leukemia
- gastrointestinal tumors such as colorectal and gastric cancer
- urothelial carcinoma in refractory settings
Research emphasizes precision medicine approaches and novel combination regimens to improve survival outcomes.
Cardiovascular Medicine
Clinical investigations focus on acute coronary events, heart failure phenotypes, and arrhythmic disorders, aiming to refine therapeutic pathways for high‑risk cardiac patients.
- Acute coronary syndrome management
- heart failure with preserved ejection fraction interventions
- atrial fibrillation treatment strategies
- hypertrophic cardiomyopathy disease‑modifying trials
- transthyretin amyloid cardiomyopathy therapeutic evaluation
Efforts target reduction of cardiovascular morbidity and mortality through innovative drug and device studies.
Infectious Diseases
The investigator’s work includes community‑based studies on viral infections, with a particular emphasis on pandemic response and outpatient therapeutic effectiveness.
- COVID‑19 treatment protocols in primary care
- Antiviral therapy assessment for emerging respiratory viruses
- Evaluation of supportive care measures for severe viral illness
- Prevention strategies for healthcare‑associated infections
- Outcomes of vaccination in immunocompromised cohorts
Studies aim to optimize rapid response frameworks and improve patient recovery trajectories.
Neurology & Neurodegeneration
Research activities address cerebrovascular events and neurogenetic disorders, seeking to mitigate functional decline and enhance quality of life.
- ischemic stroke acute management and secondary prevention
- cerebral palsy therapeutic interventions
- Huntington's disease disease‑modifying trials
- Neuroprotective strategies for traumatic brain injury
- Assessment of cognitive outcomes in chronic neurological conditions
Focus includes both acute care pathways and long‑term disease modulation.
Rare & Genetic Disorders
The investigator engages in studies of low‑prevalence conditions, emphasizing molecular diagnostics and targeted therapies for hereditary and protein‑misfolding diseases.
- AL amyloidosis therapeutic evaluation
- transthyretin amyloidosis disease‑specific interventions
- genetic dilated cardiomyopathy carrier‑focused trials
- mitochondrial myopathy treatment exploration
- Gorlin syndrome management strategies
Efforts aim to translate molecular insights into clinically meaningful outcomes for patients with rare diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.